pamidronate has been researched along with Osteomalacia in 8 studies
Osteomalacia: Disorder caused by an interruption of the mineralization of organic bone matrix leading to bone softening, bone pain, and weakness. It is the adult form of rickets resulting from disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis.
Excerpt | Relevance | Reference |
---|---|---|
"Inhibition of skeletal mineralisation is a well-recognized complication of disodium etidronate therapy that was identified in the earliest studies of its use in osteoporosis and Paget's disease." | 3.70 | Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease. ( MacGowan, JR; Morris, VH; Pringle, J; Stamp, TC, 2000) |
"Pamidronate treatment was associated with development of adynamic bone histology." | 2.71 | Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. ( Bognar, I; Burris, L; Coco, M; Durkin, P; Faugere, MC; Figueroa, K; Glicklich, D; Greenstein, S; Malluche, H; McDonough, P; Schechner, R; Tellis, V; Wang, G, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Florez, H | 1 |
Mandelikova, S | 1 |
Filella, X | 1 |
Monegal, A | 1 |
GuaƱabens, N | 1 |
Peris, P | 1 |
Rosen, CJ | 1 |
Brown, S | 1 |
Coco, M | 1 |
Glicklich, D | 1 |
Faugere, MC | 1 |
Burris, L | 1 |
Bognar, I | 1 |
Durkin, P | 1 |
Tellis, V | 1 |
Greenstein, S | 1 |
Schechner, R | 1 |
Figueroa, K | 1 |
McDonough, P | 1 |
Wang, G | 1 |
Malluche, H | 1 |
Solomon, CG | 1 |
Dluhy, RG | 1 |
Adamson, BB | 2 |
Gallacher, SJ | 2 |
Byars, J | 2 |
Ralston, SH | 2 |
Boyle, IT | 2 |
Boyce, BF | 2 |
Reid, IR | 1 |
Cundy, T | 1 |
Ibbertson, HK | 1 |
King, AR | 1 |
MacGowan, JR | 1 |
Pringle, J | 1 |
Morris, VH | 1 |
Stamp, TC | 1 |
1 trial available for pamidronate and Osteomalacia
Article | Year |
---|---|
Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Bone Density; Diphosphonates; Female; Hormones; Humans; Imm | 2003 |
7 other studies available for pamidronate and Osteomalacia
Article | Year |
---|---|
Clinical significance of increased serum levels of FGF-23 in fibrous dysplasia.
Topics: Adult; Aged; Alendronate; Biomarkers; Bone Density Conservation Agents; Female; Fibroblast Growth Fa | 2018 |
Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency.
Topics: Diphosphonates; Female; Gastroplasty; Humans; Hypocalcemia; Infusions, Intravenous; Malabsorption Sy | 2003 |
Paraneoplastic endocrine syndromes.
Topics: Acromegaly; Adrenocorticotropic Hormone; Aminoglutethimide; Bromocriptine; Calcitonin; Cushing Syndr | 1994 |
Mineralisation defects with pamidronate therapy for Paget's disease.
Topics: Calcification, Physiologic; Diphosphonates; Female; Humans; Male; Osteitis Deformans; Osteomalacia; | 1993 |
Osteomalacia after pamidronate for Paget's disease.
Topics: Diphosphonates; Humans; Osteitis Deformans; Osteomalacia; Pamidronate | 1994 |
Mineralisation defects after pamidronate for Paget's disease.
Topics: Calcification, Physiologic; Diphosphonates; Humans; Hyperparathyroidism, Secondary; Osteitis Deforma | 1994 |
Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease.
Topics: Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Arthralgia; Diphosphonates; Etidronic Acid; Fo | 2000 |